Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have a confirmed diagnosis of a neuroendocrine tumour (NET), either through a tissue sample test or through a specific type of scan (Gallium-68 PET scan) combined with an advanced imaging scan (CT scan or MRI)
- People whose NET diagnosis was made no more than one year before signing the consent form to join this trial
- People whose tumour is graded G1, G2, or G3 according to the 2019 World Health Organization classification system (confirm with trial site)
- People whose tumour started in the digestive system (such as the stomach, intestines, or pancreas), or whose tumour origin is unknown
- People who have signed the trial's consent form
Who may not be able to join:
- People whose tumour is known to have started somewhere other than the digestive system
- People who do not have a confirmed NET diagnosis through either a tissue sample test or a Gallium-68 PET scan combined with an advanced imaging scan (CT scan or MRI)
- People whose NET was diagnosed more than one year before signing the trial consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: MASSIMO FALCONI, San Raffaele Hospital
Phone: +390633775605
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of GEP-NET in Italy; Different localisations of primary GEP-NET; Time between symptoms appearance and diagnosis of GEP-NET; Type of used and available treatments (medical and surgical)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.